{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:09:55Z","timestamp":1784232595234,"version":"3.55.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100031644","name":"Zambon Italia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031644","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.rmed.2024.107865","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T21:09:46Z","timestamp":1731704986000},"page":"107865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The precision medicine strategy to treat COPD pulmonary traits in clinical practice: The role of N-acetylcysteine"],"prefix":"10.1016","volume":"235","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2667-077X","authenticated-orcid":false,"given":"Giulia","family":"Scioscia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5649-8409","authenticated-orcid":false,"given":"Federico","family":"Baraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1970-9653","authenticated-orcid":false,"given":"Tommaso","family":"Bigoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6924-4500","authenticated-orcid":false,"given":"Alberto","family":"Papi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8265-3037","authenticated-orcid":false,"given":"Alessandro","family":"Vatrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1138-3882","authenticated-orcid":false,"given":"Claudio","family":"Micheletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Foschino Barbaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rmed.2024.107865_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00164-2019","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019","volume":"53","author":"Singh","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2024.107865_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","article-title":"Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis","volume":"10","author":"Adeloye","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2024.107865_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/1479973121994572","article-title":"The burden of chronic respiratory diseases in adults in Nepal: a systematic review","volume":"18","author":"Ekezie","year":"2021","journal-title":"Chron. Respir. Dis."},{"issue":"11","key":"10.1016\/j.rmed.2024.107865_bib5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.5588\/ijtld.19.0397","article-title":"The GOLD Summit on chronic obstructive pulmonary disease in low- and middle- income countries","volume":"23","author":"Halpin","year":"2019","journal-title":"Int. J. Tubercul. Lung Dis."},{"key":"10.1016\/j.rmed.2024.107865_bib6","article-title":"Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019","volume":"378","author":"Safiri","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.rmed.2024.107865_bib7","unstructured":"World Health Organization. Projections of mortality and causes of death, 2016 and 2060, online information available here: https:\/\/colinmathers.com\/2022\/05\/10\/projections-of-global-deaths-from-2016-to-2060\/[accessed Oct 2023]."},{"issue":"3","key":"10.1016\/j.rmed.2024.107865_bib8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2471\/BLT.21.286870","article-title":"Prevalence of chronic obstructive pulmonary disease and chronic bronchitis in eight countries: a systematic review and meta-analysis","volume":"100","author":"Jarhyan","year":"2022","journal-title":"Bull. World Health Organ."},{"issue":"2","key":"10.1016\/j.rmed.2024.107865_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193143","article-title":"Chronic obstructive pulmonary disease (COPD) as a disease of early aging: evidence from the EpiChron cohort","volume":"13","author":"Divo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2024.107865_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01655-2017","article-title":"Precision medicine in airway diseases: moving to clinical practice","volume":"50","author":"Agust\u00ed","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107865_bib11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/thx.2005.052449","article-title":"Lung function decline and outcomes in an elderly population","volume":"61","author":"Mannino","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2024.107865_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1378\/chest.08-1419","article-title":"COPD as a disease of accelerated lung aging","volume":"135","author":"Ito","year":"2009","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.rmed.2024.107865_bib13","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/resp.12642","article-title":"COPD and its comorbidities: impact, measurement and mechanisms","volume":"20","author":"Negewo","year":"2015","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.rmed.2024.107865_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1183\/09031936.06.00124605","article-title":"Global burden of COPD: systematic review and meta-analysis","volume":"28","author":"Halbert","year":"2006","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.rmed.2024.107865_bib15","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.rmed.2015.10.012","article-title":"Prevalence and underdiagnosis of airway obstruction among middle-aged adults in northern France: the ELISABET study 2011-2013","volume":"109","author":"Quach","year":"2015","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2024.107865_bib16","first-page":"199","article-title":"Hypoxemia in patients with COPD: cause, effects, and disease progression","volume":"6","author":"Kent","year":"2011","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2024.107865_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD Executive Summary","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107865_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S2213-2600(18)30529-0","article-title":"Lung function trajectories in health and disease","volume":"7","author":"Agusti","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2024.107865_bib19","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/S0140-6736(05)66781-5","article-title":"\u03b11-antitrypsin deficiency","volume":"365","author":"Stoller","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2024.107865_bib20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107865_bib21","unstructured":"Centre of Excellence \u2013 Treatable traits. https:\/\/treatabletraits.org.au\/about\/#:\u223c:text=Treatable\/20traits\/20are\/20phenotypic\/20or,as\/20adherence\/20and\/20inhaler\/20technique."},{"key":"10.1016\/j.rmed.2024.107865_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/resp.13389","article-title":"Treatable traits can be identified in a severe asthma registry and predict future exacerbations","volume":"24","author":"McDonald","year":"2019","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2024.107865_bib23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(10)61087-2","article-title":"Asthma in the older adult","volume":"374","author":"Gibson","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.rmed.2024.107865_bib24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1183\/09031936.06.00152205","article-title":"Potential misclassification of causes of death from COPD","volume":"28","author":"Jensen","year":"2006","journal-title":"Eur. Respir. J."},{"issue":"9589","key":"10.1016\/j.rmed.2024.107865_bib25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","article-title":"International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study","volume":"370","author":"Buist","year":"2007","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.rmed.2024.107865_bib26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S2213-2600(13)70164-4","article-title":"Global differences in lung function by region (PURE): an international, community-based prospective study","volume":"1","author":"Duong","year":"2013","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2024.107865_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00239-2023","article-title":"Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary","volume":"61","author":"Agust\u00ed","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2024.107865_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.arbres.2024.03.010","article-title":"N-Acetylcysteine treatment in chronic obstructive pulmonary disease (COPD) and chronic bronchitis\/pre-COPD: distinct meta-analyses","volume":"60","author":"Papi","year":"2024","journal-title":"Arch. Bronconeumol."},{"issue":"171","key":"10.1016\/j.rmed.2024.107865_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0143-2023","article-title":"From treatable traits to GETomics in airway disease: moving towards clinical practice","volume":"33","author":"Papi","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"6","key":"10.1016\/j.rmed.2024.107865_bib30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1164\/rccm.202303-0450OC","article-title":"FEV1\/FVC severity stages for chronic obstructive pulmonary disease","volume":"208","author":"Bhatt","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107865_bib31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/thoraxjnl-2013-203602","article-title":"Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?","volume":"69","author":"Vanfleteren","year":"2014","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.rmed.2024.107865_bib32","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1377\/hlthaff.2017.1624","article-title":"Precision medicine: from science to value","volume":"37","author":"Ginsburg","year":"2018","journal-title":"Health Aff (Millwood)"},{"issue":"5","key":"10.1016\/j.rmed.2024.107865_bib33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary","volume":"195","author":"Vogelmeier","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2024.107865_bib34","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.rmed.2024.107865_bib35","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S2213-2600(17)30434-4","article-title":"Lung function in early adulthood and health in later life: a transgenerational cohort analysis","volume":"5","author":"Agust\u00ed","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2024.107865_bib36","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2147\/COPD.S330817","article-title":"Treatable traits in COPD - a proposed approach","volume":"16","author":"Cardoso","year":"2021","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2024.107865_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106921","article-title":"Frequent productive cough: symptom burden and future exacerbation risk among patients with asthma and\/or COPD in the NOVELTY study","volume":"200","author":"Hughes","year":"2022","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2024.107865_bib38","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am. Rev. Respir. Dis."},{"issue":"4","key":"10.1016\/j.rmed.2024.107865_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thorax.58.4.339","article-title":"Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)","volume":"58","author":"Birring","year":"2003","journal-title":"Thorax"},{"issue":"Suppl 7","key":"10.1016\/j.rmed.2024.107865_bib40","first-page":"S728","article-title":"An update on measurement and monitoring of cough: what are the important study endpoints?","volume":"6","author":"Spinou","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.rmed.2024.107865_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/8840594","article-title":"Mucus hypersecretion in chronic obstructive pulmonary disease and its treatment","volume":"2023","author":"Shah","year":"2023","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.rmed.2024.107865_bib42","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1164\/rccm.201210-1843CI","article-title":"Chronic bronchitis and chronic obstructive pulmonary disease","volume":"187","author":"Kim","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2024.107865_bib43","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1183\/23120541.00934-2020","article-title":"Treatable traits in an English cohort: prevalence and predictors of future decline in lung function and quality of life in COPD","volume":"7","author":"Sarwar","year":"2021","journal-title":"ERJ Open Res"},{"issue":"2","key":"10.1016\/j.rmed.2024.107865_bib44","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02470-2016","article-title":"Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease","volume":"50","author":"Lahousse","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmed.2024.107865_bib45","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1378\/chest.10-2948","article-title":"The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study","volume":"140","author":"Kim","year":"2011","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.rmed.2024.107865_bib46","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.3390\/cells10113263","article-title":"Treatable traits in chronic respiratory disease: a comprehensive review","volume":"10","author":"Lee","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.rmed.2024.107865_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105598","article-title":"Small airway fibrosis in COPD","volume":"116","author":"Barnes","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"12","key":"10.1016\/j.rmed.2024.107865_bib48","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/resp.14610","article-title":"The treatable traits approach to adults with obstructive airways disease in primary and secondary care","volume":"28","author":"Thomas","year":"2023","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.rmed.2024.107865_bib49","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0118-2021","article-title":"The use of treatable traits to address COPD complexity and heterogeneity and to inform the care","volume":"17","author":"Duszyk","year":"2021","journal-title":"Breathe"},{"key":"10.1016\/j.rmed.2024.107865_bib50","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/all.13760","article-title":"Inflammatory endotypes in COPD","volume":"74","author":"Barnes","year":"2019","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.rmed.2024.107865_bib51","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/15412555.2018.1476475","article-title":"Neutrophilic inflammation in the pathogenesis of chronic obstructive pulmonary disease","volume":"15","author":"Butler","year":"2018","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2024.107865_bib52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12931-015-0221-7","article-title":"Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation","volume":"16","author":"Grabcanovic-Musija","year":"2015","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.rmed.2024.107865_bib53","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3904\/kjim.2015.084","article-title":"Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study","volume":"31","author":"Lee","year":"2016","journal-title":"Korean J Intern Med"},{"issue":"4","key":"10.1016\/j.rmed.2024.107865_bib54","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1183\/13993003.00961-2015","article-title":"The double-edged sword of neutrophilic inflammation in bronchiectasis","volume":"46","author":"Mart\u00ednez-Garc\u00eda","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2024.107865_bib55","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/jcm9061639","article-title":"Current challenges in chronic bronchial infection in patients with chronic obstructive pulmonary disease","volume":"9","author":"Lopez-Campos","year":"2020","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.rmed.2024.107865_bib56","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/thx.2006.075937","article-title":"Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD","volume":"62","author":"Grootendorst","year":"2007","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.rmed.2024.107865_bib57","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1164\/rccm.202303-0455CI","article-title":"Targeting type 2 inflammation and epithelial alarmins in chronic obstructive pulmonary disease: a biologics outlook","volume":"208","author":"Rabe","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107865_bib58","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaip.2023.01.011","article-title":"Treatable traits in airway disease: from theory to practice","volume":"11","author":"Agust\u00ed","year":"2023","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.rmed.2024.107865_bib59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaip.2015.01.013","article-title":"Biologic therapies targeting eosinophils: current status and future prospects","volume":"3","author":"Legrand","year":"2015","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.rmed.2024.107865_bib60","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/ph16020270","article-title":"Biologic therapies for asthma and allergic disease: past, present, and future","volume":"16","author":"Ram\u00edrez-Jim\u00e9nez","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.rmed.2024.107865_bib61","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1513\/pats.200508-094DO","article-title":"Why does the lung hyperinflate?","volume":"3","author":"Ferguson","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"3","key":"10.1016\/j.rmed.2024.107865_bib62","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1183\/23120541.00322-2019","article-title":"Treatment of severe stable COPD: the multidimensional approach of treatable traits","volume":"6","author":"van Dijk","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmed.2024.107865_bib63","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1164\/rccm.201208-1518OC","article-title":"Prognostic value of bronchiectasis in patients with moderate\u2010to\u2010severe chronic obstructive pulmonary disease","volume":"187","author":"Martinez\u2010Garcia","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107865_bib64","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.3390\/jcm10122736","article-title":"Computed tomography in adults with bronchiectasis and nontuberculous mycobacterial pulmonary disease: typical imaging findings","volume":"10","author":"Dettmer","year":"2021","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.rmed.2024.107865_bib65","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2024.107865_bib66","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2024.107865_bib67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00408-023-00597-8","article-title":"Tiotropium in patients with bronchiectasis: a prospective cohort study","volume":"201","author":"Shi","year":"2023","journal-title":"Lung"},{"key":"10.1016\/j.rmed.2024.107865_bib68","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2147\/COPD.S205075","article-title":"Effects of long-term macrolide therapy at low doses in stable copd","volume":"14","author":"Cao","year":"2019","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"9589","key":"10.1016\/j.rmed.2024.107865_bib69","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"Wedzicha","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rmed.2024.107865_bib70","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MCP.0b013e32835d8312","article-title":"Chronic obstructive pulmonary disease and bronchiectasis","volume":"19","author":"Novosad","year":"2013","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"5","key":"10.1016\/j.rmed.2024.107865_bib71","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/thx.2007.090613","article-title":"Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies","volume":"63","author":"El Moussaoui","year":"2008","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2024.107865_bib72","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12890-022-01958-4","article-title":"Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis","volume":"22","author":"Hoult","year":"2022","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.rmed.2024.107865_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101544","article-title":"Oxidative stress-based therapeutics in COPD","volume":"33","author":"Barnes","year":"2020","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.rmed.2024.107865_bib74","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/resp.14325","article-title":"Treatable traits in the NOVELTY study","volume":"27","author":"Agust\u00ed","year":"2022","journal-title":"Respirology"},{"issue":"Suppl 64","key":"10.1016\/j.rmed.2024.107865_bib75","first-page":"124","article-title":"Dysfunctional breathing impacts symptom burden in chronic obstructive pulmonary disease (COPD)","volume":"56","author":"Lapperre","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2024.107865_bib76","doi-asserted-by":"crossref","DOI":"10.1590\/1806-3713\/e20170347","article-title":"Dysfunctional breathing: what do we know?","volume":"45","author":"Vidotto","year":"2019","journal-title":"J. Bras. Pneumol."},{"issue":"2","key":"10.1016\/j.rmed.2024.107865_bib77","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00700-2023","article-title":"Revisiting asthma pharmacotherapy: where do we stand and where do we want to go?","volume":"62","author":"Cazzola","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.rmed.2024.107865_bib78","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/10715762.2018.1468564","article-title":"N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why","volume":"52","author":"Aldini","year":"2018","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.rmed.2024.107865_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107916","article-title":"The mechanism of action of N-acetylcysteine (NAC): the emerging role of H2S and sulfane sulfur species","volume":"228","author":"Pedre","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.rmed.2024.107865_bib80","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.04.015","article-title":"Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review","volume":"55","author":"Deepmala","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.rmed.2024.107865_bib81","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.4088\/JCP.15r09984","article-title":"N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis","volume":"77","author":"Fernandes","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"14","key":"10.1016\/j.rmed.2024.107865_bib82","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/ars.2020.8247","article-title":"N-acetylcysteine and hydrogen sulfide in coronavirus disease 2019","volume":"35","author":"Bourgonje","year":"2021","journal-title":"Antioxidants Redox Signal."},{"issue":"2","key":"10.1016\/j.rmed.2024.107865_bib83","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/ph15020217","article-title":"N-Acetylcysteine (NAC) and its role in clinical practice management of cystic fibrosis (CF): a review","volume":"15","author":"Guerini","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.rmed.2024.107865_bib84","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chembiol.2018.01.011","article-title":"N-acetyl cysteine functions as a fast-acting antioxidant by triggering intracellular H2S and sulfane sulfur production","volume":"25","author":"Ezeri\u0146a","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"3","key":"10.1016\/j.rmed.2024.107865_bib85","first-page":"89","article-title":"Effect of N-acetylcysteine on mucosal immunity of respiratory tract","volume":"90","author":"Kalyuzhin","year":"2018","journal-title":"Ter. Arkh."},{"issue":"5","key":"10.1016\/j.rmed.2024.107865_bib86","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bcp.2011.05.014","article-title":"N-acetyl-L-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)","volume":"82","author":"Mata","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.rmed.2024.107865_bib87","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0014-5793(00)01464-2","article-title":"N-acetylcysteine suppresses TNF-induced NF-kappaB activation through inhibition of IkappaB kinases","volume":"472","author":"Oka","year":"2000","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.rmed.2024.107865_bib88","doi-asserted-by":"crossref","DOI":"10.52225\/narra.v3i2.121","article-title":"The role of N-acetylcysteine in decreasing neutrophil-lymphocyte ratio in COVID-19 patients: a double-blind, randomized controlled trial","volume":"3","author":"Prabowo","year":"2023","journal-title":"Narra J"},{"issue":"9","key":"10.1016\/j.rmed.2024.107865_bib89","first-page":"4316","article-title":"Rationale and evidence for the adjunctive use of N-acetylcysteine in multidrug-resistant infections","volume":"27","author":"Oliva","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.rmed.2024.107865_bib90","series-title":"Ottawa (ON): Canadian Agency for Drugs and Technologies in Health","article-title":"Acetylcysteine for patients requiring mucous secretion clearance: a review of clinical effectiveness and safety","author":"Banerjee","year":"2019"},{"issue":"6","key":"10.1016\/j.rmed.2024.107865_bib91","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/antiox10060967","article-title":"N-acetylcysteine (NAC): impacts on human health","volume":"10","author":"Ten\u00f3rio","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"8","key":"10.1016\/j.rmed.2024.107865_bib92","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/17476348.2018.1495562","article-title":"Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease","volume":"12","author":"Calzetta","year":"2018","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.rmed.2024.107865_bib93","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/COPD.S144312","article-title":"Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition)","volume":"13","author":"Shen","year":"2018","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2024.107865_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113244","article-title":"Interleukin-6 neutralizing antibody attenuates the hypersecretion of airway mucus via inducing the nuclear translocation of Nrf2 in chronic obstructive pulmonary disease","volume":"152","author":"Wei","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.rmed.2024.107865_bib95","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pupt.2010.08.002","article-title":"Arylhydrocarbon receptor (AhR) activation in airway epithelial cells induces MUC5AC via reactive oxygen species (ROS) production","volume":"24","author":"Chiba","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.rmed.2024.107865_bib96","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/1574-6968.12203","article-title":"Novel concepts in nontypeable Haemophilus influenzae biofilm formation","volume":"346","author":"Langereis","year":"2013","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.rmed.2024.107865_bib97","doi-asserted-by":"crossref","DOI":"10.1177\/17534666231158563","article-title":"The efficacy of N-acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis","volume":"17","author":"Huang","year":"2023","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"9","key":"10.1016\/j.rmed.2024.107865_bib98","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3390\/antiox12091713","article-title":"Advances in the use of N-acetylcysteine in chronic respiratory diseases","volume":"12","author":"Mokra","year":"2023","journal-title":"Antioxidants (Basel)"},{"issue":"12","key":"10.1016\/j.rmed.2024.107865_bib99","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.0511304103","article-title":"High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis","volume":"103","author":"Tirouvanziam","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.rmed.2024.107865_bib100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcf.2014.08.008","article-title":"Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial","volume":"14","author":"Conrad","year":"2015","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.rmed.2024.107865_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115173","article-title":"Protective effects and mechanisms of N-acetylcysteine on indomethacin-induced intestinal injury in a porcine model","volume":"262","author":"Zhang","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"1","key":"10.1016\/j.rmed.2024.107865_bib102","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3904\/kjim.2016.329","article-title":"N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis","volume":"34","author":"Kim","year":"2019","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.rmed.2024.107865_bib103","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8715185","article-title":"Nephroprotective effects of N-acetylcysteine amide against contrast-induced nephropathy through upregulating thioredoxin-1, inhibiting ASK1\/p38MAPK pathway, and suppressing oxidative stress and apoptosis in rats","volume":"2016","author":"Gong","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.rmed.2024.107865_bib104","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkac011","article-title":"Epithelial-mesenchymal transition in organ fibrosis development: current understanding and treatment strategies","volume":"10","author":"Liu","year":"2022","journal-title":"Burns Trauma"},{"key":"10.1016\/j.rmed.2024.107865_bib105","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2147\/COPD.S49307","article-title":"Effect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patients","volume":"8","author":"De Backer","year":"2013","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"2","key":"10.1016\/j.rmed.2024.107865_bib106","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1378\/chest.09-0421","article-title":"Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study","volume":"136","author":"Stav","year":"2009","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2024.107865_bib107","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S2213-2600(13)70286-8","article-title":"PANTHEON study group. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial","volume":"2","author":"Zheng","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"9470","key":"10.1016\/j.rmed.2024.107865_bib108","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","article-title":"Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial","volume":"365","author":"Decramer","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2024.107865_bib109","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2466-4-13","article-title":"Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]","volume":"4","author":"Black","year":"2004","journal-title":"BMC Pulm. Med."},{"issue":"1","key":"10.1016\/j.rmed.2024.107865_bib110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1378\/chest.12-2357","article-title":"High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study","volume":"144","author":"Tse","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2024.107865_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2023.102283","article-title":"Evaluation of high dose N- Acetylcysteine on airway inflammation and quality of life outcomes in adults with bronchiectasis: a randomised placebo-controlled pilot study","volume":"84","author":"Jayaram","year":"2024","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.rmed.2024.107865_bib112","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejcdt.2013.02.012","article-title":"High dose N-acetyl cysteine improves inflammatory response and outcome in patients with COPD exacerbations","volume":"62","author":"El Hafiz","year":"2013","journal-title":"Egypt. J. Chest Dis. Tuberc."},{"issue":"137","key":"10.1016\/j.rmed.2024.107865_bib113","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1183\/16000617.00002215","article-title":"Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis","volume":"24","author":"Cazzola","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2024.107865_bib114","first-page":"65","article-title":"Etude multi-centrique en double aveugle avec ac\u00e9tylcyst\u00e9ine oral vs. plac\u00e9bo [Multicenter, double-blind study of oral acetylcysteine vs. placebo]","volume":"111","author":"Brocard","year":"1980","journal-title":"Eur. J. Respir. Dis. Suppl."},{"issue":"10","key":"10.1016\/j.rmed.2024.107865_bib115","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.rmed.2007.05.010","article-title":"Changing pattern of sputum cell counts during successive exacerbations of airway disease","volume":"101","author":"D'silva","year":"2007","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2024.107865_bib116","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0119-2021","article-title":"Precision medicine in bronchiectasis","volume":"17","author":"Pembridge","year":"2021","journal-title":"Breathe"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124003408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124003408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T19:38:01Z","timestamp":1735673881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611124003408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":115,"alternative-id":["S0954611124003408"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107865","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The precision medicine strategy to treat COPD pulmonary traits in clinical practice: The role of N-acetylcysteine","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107865"}}